Bicycle Therapeutics plans dose selection update in first quarter 2026
Go back to Bicycle Therapeutics plans dose selection update in first quarter 2026| (NASDAQ: BCYC) | Delayed: 3.95 +0.05 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.90 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $4.02 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $ | |||
| Volume | 45,013 | |||||

